Ancora Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 385 shares of CRL stock, worth $74,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares

385

Previous 10,445 96.31%

Holding current value

$74,763

Previous $2.16 Million 96.52%

% of portfolio

0.0%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $1.89 Million - $2.47 Million	-10,060 Reduced 96.31%	385 $75,000
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $1.44 Million - $1.88 Million	-6,995 Reduced 40.11%	10,445 $2.16 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $36,430 - $48,943	-179 Reduced 1.02%	17,440 $4.73 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $114,505 - $166,232	-696 Reduced 3.8%	17,619 $4.17 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $1.19 Million - $1.34 Million	-6,136 Reduced 25.1%	18,315 $3.59 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $2.55 Million - $2.92 Million	13,885 Added 131.41%	24,451 $5.14 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $516,184 - $699,184	-2,690 Reduced 20.29%	10,566 $2.13 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $1.6 Million - $2.03 Million	8,100 Added 157.1%	13,256 $2.89 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $820,980 - $1.13 Million	4,500 Added 685.98%	5,156 $1.02 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $14,289 - $21,168	-70 Reduced 9.64%	656 $140,000
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $5.14 Million - $7.29 Million	-20,120 Reduced 96.52%	726 $206,000
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $2.64 Million - $3.74 Million	10,341 Added 98.44%	20,846 $6.04 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $2.66 Million - $3.4 Million	-7,580 Reduced 41.91%	10,505 $3.96 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $905,887 - $1.11 Million	-2,431 Reduced 11.85%	18,085 $7.46 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $97,076 - $122,644	-330 Reduced 1.58%	20,516 $7.59 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $426,935 - $512,110	-1,710 Reduced 7.58%	20,846 $6.04 Million
Q4 2020 Feb 12, 2021	SELL	$222.0 - $252.62 $51,060 - $58,102	-230 Reduced 1.01%	22,556 $5.64 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $2.8 Million - $3.61 Million	-15,930 Reduced 41.15%	22,786 $5.16 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $2.8 Million - $4.46 Million	-23,520 Reduced 37.79%	38,716 $6.75 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $409,446 - $738,327	4,140 Added 7.13%	62,236 $7.86 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $1,764 - $2,138	-14 Reduced 0.02%	58,096 $8.88 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $1.43 Million - $1.64 Million	11,400 Added 24.41%	58,110 $7.69 Million
Q2 2019 Nov 14, 2019	SELL	$123.4 - $148.55 $2.3 Million - $2.77 Million	-18,668 Reduced 28.55%	46,710 $9.28 Million
Q2 2019 Aug 12, 2019	BUY	$123.4 - $148.55 $8.07 Million - $9.71 Million	65,378 New	65,378 $9.28 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.88B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Charles River Laboratories International, Inc. Transaction History